BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ingredientpharm - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ingredientpharm.com
X-WR-CALDESC:Events for Ingredientpharm
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260331
DTEND;VALUE=DATE:20260403
DTSTAMP:20260112T143941Z
CREATED:20260112T143941Z
LAST-MODIFIED:20260112T143941Z
UID:2205-1774915200-1775174399@ingredientpharm.com
SUMMARY:World Vaccine Congress in Washington 2026
DESCRIPTION:The World Vaccine Congress in Washington 2026 stands among the most influential global events for vaccines and immunotherapy innovation. Each year in Washington\, D.C.\, it convenes leaders from science\, industry\, regulation\, public health\, and investment. Together\, participants address critical challenges and breakthroughs in vaccine research\, development\, and manufacturing. As the world’s largest vaccine-focused meeting\, it represents a key milestone across the global vaccine ecosystem. \nIn 2026\, the congress will again examine the full spectrum of vaccine science and technology. Specifically\, sessions span basic immunology\, antigen discovery\, clinical development\, regulatory science\, and manufacturing scale-up. Moreover\, the agenda features mRNA platforms\, viral vectors\, recombinant vaccines\, adjuvants\, AI-driven research\, and pandemic preparedness. In addition\, discussions cover global health policy\, supply-chain resilience\, therapeutic vaccines\, and next-generation production tools. \nAttendees include vaccine developers\, pharmaceutical manufacturers\, biotech innovators\, and academic researchers. Likewise\, epidemiologists\, policymakers\, investors\, NGOs\, and global health organizations actively participate. Government agencies such as the FDA\, NIH\, BARDA\, and CDC also play a central role. Consequently\, the congress aligns scientific progress\, regulatory strategy\, and commercial decision-making. \nFurthermore\, the World Vaccine Congress in Washington 2026 delivers exceptional networking and business development opportunities. Companies showcase emerging technologies\, explore partnerships\, and gain insight into global regulatory expectations. Meanwhile\, researchers access cutting-edge data\, while policymakers examine frameworks to strengthen immunization and preparedness. Therefore\, the event strongly benefits organizations across biotechnology\, pharmaceuticals\, diagnostics\, AI\, and supply-chain solutions. \nSPI Pharma\, a global leader in vaccine adjuvants\, excipients\, and drug delivery solutions\, accelerates vaccine innovation worldwide. At the congress\, SPI Pharma will present its portfolio on adjuvant technologies to support stronger immune responses and scalable vaccine development. Do not forget talking on ACTILLETS™ (SPI branded CELLETS®) or TAP®\, both pelletized excipients made for modern pharmaceutical formulations. Additionally\, company experts will discuss advanced adjuvant systems developed with partners to expand accessible\, effective vaccine options. Through these contributions\, SPI Pharma aims to strengthen vaccine design and global immunization impact at WVC 2026. \nBy uniting leading vaccine and immunotherapy experts\, the 2026 congress accelerates innovation and advances global health strategies. As a result\, it will help shape the next generation of vaccines worldwide.
URL:https://ingredientpharm.com/event/world-vaccine-congress-in-washington-2026/
LOCATION:Walter E. Washington Convention Center\, 801 Allen Y. Lew Place NW\, Washington DC\, DC\, 20001\, United States
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/World-Vaccine-Congress-Washington.jpg
ORGANIZER;CN="Terrapinn Holdings Ltd":MAILTO:enquiry.uk@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260329
DTEND;VALUE=DATE:20260401
DTSTAMP:20260211T090602Z
CREATED:20260112T143916Z
LAST-MODIFIED:20260211T090602Z
UID:2189-1774742400-1775001599@ingredientpharm.com
SUMMARY:Asia Pharma Expo Dhaka
DESCRIPTION:Asia Pharma Expo (APE)\, launched in 2003\, has become one of South Asia’s most important pharmaceutical industry platforms. Consequently\, its name reflects Asia’s diverse\, fast-growing\, and strategically vital pharmaceutical market globally. \nHeld annually at the Bangladesh–China Friendship Exhibition Center (BCFEC) in Dhaka\, the expo attracts both regional and global stakeholders. Therefore\, this location highlights Bangladesh’s growing pharmaceutical influence and reinforces Dhaka as a major South Asian commercial hub. \nOrganized by GPE Expo Pvt. Ltd.\, a leading international trade fair specialist\, Asia Pharma Expo unites local and global exhibitors\, professionals\, and decision-makers. Each year\, it showcases innovations\, technologies\, and services shaping the pharmaceutical future. \nThe expo spans pharmaceuticals\, nutraceuticals\, biotechnology\, cosmetics\, and healthcare solutions. Key features include processing machinery\, APIs\, bulk drug intermediates\, excipients\, cleanroom technologies\, water treatment\, and integrated management systems. As a result\, it serves as a dynamic networking hub for knowledge exchange\, partnerships\, and business discovery. \nExhibitors include pharmaceutical manufacturers\, biotech firms\, medical technology producers\, and service providers. Meanwhile\, visitors include CEOs\, senior executives\, R&D\, quality assurance\, production\, and procurement professionals\, making it ideal for high-level business interactions. \nRelated Topics\n\nPharmaceutical Excipients\nPharmaceutical Packaging Machinery\nPharmaceutical Ingredients Suppliers\nPharma Contract Manufacturing\nCleanroom Equipment Dhaka\n\nThe BCFEC offers a modern\, well-equipped venue with excellent transport links\, convenient for domestic and international participants. Moreover\, Dhaka combines cultural heritage with rapid industrial growth\, increasing the event’s appeal. \nAsia Pharma Expo 2026 will run three days\, from 29 March to 31 March 2026\, in Purbachal\, Dhaka\, Bangladesh.
URL:https://ingredientpharm.com/event/asia-pharma-expo-dhaka/
LOCATION:Bangladesh-China Friendship Exhibition Center\, Purbachal New Town Project\, Dhaka\, RGVM+6R\, Bangladesh
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/Asia-Pharma-Expo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260304T160608Z
CREATED:20260112T143934Z
LAST-MODIFIED:20260304T160608Z
UID:2194-1774224000-1774569599@ingredientpharm.com
SUMMARY:DCAT Week 2026
DESCRIPTION:DCAT Week 2026 is a leading global meeting for the pharmaceutical manufacturing value chain. Organized by DCAT\, it occurs in New York City each March. Senior executives from pharma companies and key development\, manufacturing\, sourcing\, and supply partners meet there for interdisciplinary exchange. \n\nLet’s talk on CDMO solutions and clinical supplies during DCAT: Book time to meet with Philippe \n\nDCAT Week facilitates strategic meetings among innovator pharma\, generic manufacturers\, contract service providers\, technology developers\, and suppliers. In 2026\, the event will let industry leaders discuss market trends\, form partnerships\, negotiate supply agreements\, and explore emerging technologies shaping drug development and commercialization. \nThe event covers topics like global supply chains\, advanced manufacturing\, sourcing strategies\, drug substance and product innovation\, biologics\, cell and gene therapies\, sustainability\, digital transformation\, regulatory updates\, and portfolio management. These subjects appear in keynotes\, educational programs\, networking events\, and private business meetings across Midtown Manhattan. \nSPI Pharma will inform on starter spheres for extended release formulation designs \nAttendees include C-suite executives\, procurement directors\, supply-chain strategists\, R&D and technical leaders\, business development managers\, and regulatory specialists from major pharma companies\, CDMOs\, CMOs\, API manufacturers\, excipient suppliers\, technology providers\, packaging firms\, and logistics companies. This exclusive environment enables meaningful interactions\, making it one of the industry’s most valuable annual gatherings. \nDCAT 2026 offers companies opportunities to strengthen global partnerships\, increase visibility among top buyers. Also take the chance to understand market dynamics\, and identify innovations that improve manufacturing and supply reliability. Its concentration of industry leaders in one city creates an unmatched platform for strategic collaboration and competitive intelligence.
URL:https://ingredientpharm.com/event/dcat-week-2026/
LOCATION:New York Hilton Midtown Grand Ballroom\, 1335 6th Ave\, New York\, NY\, 10019\, United States
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/DCAT-2026.jpeg
ORGANIZER;CN="DCAT Global Headquarters":MAILTO:info@dcat.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260304T160947Z
CREATED:20260112T103655Z
LAST-MODIFIED:20260304T160947Z
UID:2199-1774224000-1774569599@ingredientpharm.com
SUMMARY:15th PBP World Meeting on Pharmaceutics\, Biopharmaceutics and Pharmaceutical Technology
DESCRIPTION:15th PBP World Meeting will take place in Prague/CZ in March 23-26\, 2026 and will continue its strong international reputation. The conference ranks among the most respected scientific meetings in pharmaceutical science. Moreover\, it operates under the Pharmaceutical Technology platform with support from leading academic and industry partners. As a result\, it serves as a key global forum for advanced research in drug development and formulation science. \nThe 15th PBP World Meeting brings together innovation\, applied research\, and regulatory perspectives. Therefore\, it supports knowledge exchange at a high scientific level. In addition\, it strengthens collaboration between academia and industry. \nScientific Focus of the 15th PBP World Meeting\nPBP focuses on current advances in pharmaceutics and biopharmaceutics. In particular\, it addresses novel drug delivery systems and modern formulation technologies. Moreover\, the scientific program explores predictive modeling\, continuous manufacturing\, and nanomedicine. \nIn addition\, sessions examine regulatory-science integration and its growing role in development strategies. Therefore\, participants gain practical insight into evolving approval expectations. The program also covers pharmaceutical 3D printing\, personalized medicine\, innovative excipients\, and quality-by-design strategies. Furthermore\, advanced analytical methods receive strong attention as enablers of efficient product development. \nThe conference emphasizes research quality and scientific depth. As a result\, oral sessions and poster presentations highlight how innovation shapes future pharmaceutical manufacturing. \nParticipants and Collaboration Opportunities\nThe 15th PBP World Meeting attracts a highly specialized international audience. It welcomes academic researchers\, formulation scientists\, biopharmaceutical experts\, and R&D managers. In addition\, regulatory professionals and technology developers attend from pharmaceutical and biotechnology companies. \nTherefore\, the meeting creates a productive environment for scientific exchange. Moreover\, it encourages direct interaction between research institutions and industry leaders. Participants can build partnerships for development projects and technology transfer. As a result\, collaboration extends beyond the conference itself. \nThe World Meeting also supports companies that seek scientific visibility. Consequently\, organizations involved in excipients\, analytical technologies\, drug delivery systems\, and manufacturing equipment benefit from targeted engagement. \nIndustry Scope and Location Advantage\nIndustries represented at the 15th PBP World Meeting include pharmaceuticals\, biotechnology\, analytical instrumentation\, and advanced manufacturing. In addition\, research organizations focused on formulation science and therapeutic innovation play a central role. \nPrague offers strong advantages as the host city. Moreover\, it provides excellent international accessibility and a rich scientific tradition. Therefore\, the location enhances both attendance and collaboration. \nIn conclusion\, the 15th PBP World Meeting delivers high scientific value\, strong networking potential\, and clear industry relevance. As a result\, it remains an essential event for professionals in pharmaceutical science and technology.
URL:https://ingredientpharm.com/event/15th-pbp-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology/
LOCATION:Holiday Inn Prague Congress Centre\, Na Pankráci 1684/ 15\, Praha\, 140 00\, Czech Republic
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/PBP-2026.jpeg
ORGANIZER;CN="Arbeitsgemeinschaft f%C3%BCr Pharmazeutische Verfahrenstechnik e. V. (APV)":MAILTO:info@apv-mainz.de
END:VEVENT
END:VCALENDAR